齐晓龙

Qi Xiaolong

智库特邀高级顾问
Special Senior Advisor
澳洲 CSU 大学 MBA
Senior Engineer Australia CSU University MBA
德国 RWTH 大学生物学博士
Doctor of Biology, RWTH University, Germany

【研究方向 Research Fields】

大健康产业研究

Research on big health industry

社会职务Social Titles

德国学者会理事
Council member of the German Society of Scholars
德国门兴格拉德巴赫市(Moenchengladbach)政府经贸局中国代表
Representative of the Economic and Trade Bureau of the Government of Moenchengladbach, Germany
德国明斯特市 (Muester) 教育局 BIMS 职业中心中国代表
China representative of BIMS Career Center, Education Bureau, Muester, Germany
德国隐形冠军企业联盟中国区首席代表
Chief representative of Germany invisible champion enterprise union in China
中国卫生医药事业发展基金会医疗大健康国际创新营运中心主任
Director of the Medical Big Health International Innovation Operation Center of China Health and Pharmaceutical Development Foundation
国际健康与环境产业联合会(IHEIA)大中华西南区主任
Director, Southwest China Region, International Federation of Health and Environment Industries (IHEIA)
健康中国行组委会副秘书长兼决策委员
Deputy Secretary General and policy-making committee member of Health China Travel Committee
重庆中医药行业协会副主任兼特聘外籍专家
Deputy Director of Chongqing Traditional Chinese Medicine Industry Association and Specially Invited Foreign Expert

主要成果Main Outcomes

自 2012 年始带领团队专注于“TCRT-Immunzellen und Tumoren /TCRT 免疫细胞与肿瘤”“Immunglobulin-Antikörper /免疫球蛋白抗体” 方面的研究。撰写医学论文十余篇,拥有发明专利 10 余项,帮助企业研发独创型产品 3 个。于 2018 年协同团队研发及生产出了具有国际领先的最新的生物抗体制剂“诺德诺美抗HPV 及广谱灭菌生物制剂”,并且获得发明专利。目前致力于橄榄苦甙(Oleuropein)和羟基酪醇(Hydroxytyrosol)在口腔牙周疾病等领域的消炎止痛的复合型产品的研究。
Since 2012, he has led the team to focus on the research of "TCRT-Immunzellen und Tumoren /TCRT immune cells and tumors" and "Immunglobulin-antikorper/immunoglobulin antibodies". He has written more than 10 medical papers, more than 10 invention patents, and helped enterprises to develop 3 original products. In 2018, we collaborated with the team to develop and produce the latest international leading biological antibody preparation "Nordenome anti-HPV and broad-spectrum sterilization biological preparation", and obtained the invention patent. He is currently working on the synthesis of Oleuropein and Hydroxytyrosol as anti-inflammatory and analgesic products in the field of oral and periodontal diseases.